1.
Mikkael A. Sekeres, Jeffrey E. Lancet, Brent L. Wood, Laurie E. Grove, Larissa Sandalic, Eric L. Sievers, Joseph G. Jurcic. Randomized, phase IIb study of low-dose cytarabine and lintuzumab versus low-dose cytarabine and placebo in older adults with untreated acute myeloid leukemia. Haematologica 2012;98(1):119-128; https://doi.org/10.3324/haematol.2012.066613.